Elisabeth Meyer
-
- Antibiotic Use and Resistance 27
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria 19
-
- Nosocomial Infections in ICU 21
- Clinical Biochemistry top 1%
- Endocrinology top 2%
-
- Antimicrobial Resistance in Staphylococcus 13
- Clostridium difficile and Clostridium perfringens research 6
-
- Antibiotics Pharmacokinetics and Efficacy 10
-
- Urinary Tract Infections Management 8
- Pneumonia and Respiratory Infections 7
- Co-authors
- Petra GastmeierFrank SchwabRoger M. HerriottFranz DaschnerChristine GeffersB. Schroeren-BoerschUwe FrankKlaus Kaier
- Cited by
- Applied Microbiology and BiotechnologyMolecular MedicineCritical Care and Intensive Care Medicine
- Journals
- Journal of Hospital Infection (10 papers)Infection (9 papers)Journal of Antimicrobial Chemotherapy (6 papers)
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
Elisabeth Meyer
81 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 137
- Applied Microbiology and Biotechnology 772
- Molecular Medicine 686
- Critical Care and Intensive Care Medicine 379
- Clinical Biochemistry 326
- Endocrinology 205
Countries citing papers authored by Elisabeth Meyer
This map shows the geographic impact of Elisabeth Meyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Meyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Meyer more than expected).
Fields of papers citing papers by Elisabeth Meyer
This network shows the impact of papers produced by Elisabeth Meyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Meyer. The network helps show where Elisabeth Meyer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Elisabeth Meyer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2022 | 7 | |
| 3 | 2020 | 24 | |
| 4 | 2014 | 5 | |
| 5 | 2013 | 18 | |
| 6 | 2013 | 30 | |
| 7 | 2012 | 76 | |
| 8 | 2011 | 56 | |
| 9 | 2010 | 3 | |
| 10 | 2010 | 23 | |
| 11 | 2009 | 33 | |
| 12 | 2009 | 3 | |
| 13 | 2009 | 68 | |
| 14 | 2008 | 26 | |
| 15 | 2008 | 6 | |
| 16 | 2007 | 2 | |
| 17 | 2007 | 15 | |
| 18 | 2006 | 9 | |
| 19 | 2006 | 38 | |
| 20 | 2003 | 60 |
About Elisabeth Meyer
Elisabeth Meyer is a scholar working on Applied Microbiology and Biotechnology, Critical Care and Intensive Care Medicine, Molecular Medicine, Endocrinology and Infectious Diseases, having authored 86 papers that have together received 2.5k indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (27 papers), Nosocomial Infections in ICU (21 papers), Antibiotic Resistance in Bacteria (19 papers), Antimicrobial Resistance in Staphylococcus (13 papers), Antibiotics Pharmacokinetics and Efficacy (10 papers), Urinary Tract Infections Management (8 papers), Pneumonia and Respiratory Infections (7 papers) and Clostridium difficile and Clostridium perfringens research (6 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (772 citations), Molecular Medicine (686 citations), Critical Care and Intensive Care Medicine (379 citations), Clinical Biochemistry (326 citations) and Endocrinology (205 citations). Elisabeth Meyer has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Petra Gastmeier, Frank Schwab, Roger M. Herriott, Franz Daschner, Christine Geffers, B. Schroeren-Boersch, Uwe Frank, Klaus Kaier, Henning Rueden and Maria Deja. Their work appears in journals such as Journal of Hospital Infection, Infection, Journal of Antimicrobial Chemotherapy, Infection Control and Hospital Epidemiology and Intensive Care Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.